Klarvoyant Biogenics

Klarvoyant Biogenics is an India-based private pharmaceutical company operating under the legal name Delvin Klarvoyant Biogenics Private Limited. Available public evidence indicates it markets a small portfolio of commercialized products in India, including Cholebloc (atorvastatin), Epomine (recombinant human erythropoietin alfa), Valenfer (iron sucrose/ferrous sucrose), and Nabico (sodium bicarbonate). The company appears to focus on branded generics and hospital-oriented supportive care products rather than a novel clinical-stage R&D pipeline. Corporate registry sources list the company as active and unlisted, with operations centered in Chennai, Tamil Nadu. Publicly accessible information on financing, partnerships, proprietary platforms, and internal pipeline development is limited.